anti-Canine Distemper Virus (CDV), Surface envelope antigen antibody product blog
Tags: Antibody; Monoclonal Antibody; Canine Distemper Virus (CDV), Surface Envelope Antigen; anti-Canine Distemper Virus (CDV), Surface Envelope Antigen antibody;
The Canine Distemper Virus (CDV), Surface envelope antigen n/a (Catalog #MBS310517) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Canine Distemper Virus (CDV), Surface envelope antigen can be used in a range of immunoassay formats including, but not limited to, ELISA, Immunofluorescence (IF), Plaque-linked Assay.Each laboratory should determine an optimum working titer for use in its particular application.
Other applications have not been tested but use in such assays should not necessarily be excluded.
Recommended pair for sandwich immunoassay - Capture: MBS310481 / Detection: MBS310517. Researchers should empirically determine the suitability of the Canine Distemper Virus (CDV), Surface envelope antigen n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Source: Ascites
Immunogen: Purified Canine Distemper Virus envelope protein
Preservative: 0.09% Sodium Azide. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Canine Distemper Virus (CDV), Surface envelope antigen are readily searchable from our website. Different antibodies against the same target such as Canine Distemper Virus (CDV), Surface envelope antigen may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.